AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in AN2 Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +2 vs. Q3 2025
- Shares held
- 8.67M
- +388.3K (+4.7%) vs. Q3 2025
- Total value
- $9.88M
- −$633.5K (−6.0%) vs. Q3 2025
- New holders
- 5
- 9 more added
- Sold out
- 3
- 8 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 200 | $228 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $342 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 303 | $345 | 0.00% | 00.0% | Unchanged |
| Innovative Advisory Group, LLC | 1,170 | $1.33K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,200 | $1.37K | 0.00% | +200+20.0% | Added |
| Tower Research Capital LLC (TRC) | 2,040 | $2.33K | 0.00% | −88−4.1% | Reduced |
| Qube Research & Technologies Ltd | 10,184 | $11.6K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 10,446 | $11.9K | 0.00% | +10,446 | New |
| Federated Hermes, Inc. | 11,479 | $13.1K | 0.00% | −403−3.4% | Reduced |
| Schonfeld Strategic Advisors LLC | 14,281 | $16.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 17,935 | $20.4K | 0.00% | +17,935 | New |
| Susquehanna International Group, LLP | 22,240 | $25.4K | 0.00% | +22,240 | New |
| Private Advisor Group, LLC | 22,500 | $25.6K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 40,000 | $45.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 43,196 | $49.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 56,668 | $64.6K | 0.00% | −260.0% | Reduced |
| Bridgeway Capital Management, LLC | 59,900 | $68.3K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 61,612 | $70.2K | 0.00% | −2,655−4.1% | Reduced |
| Rangeley Capital, LLC | 65,000 | $74.1K | 0.06% | 00.0% | Unchanged |
| State Street Corp | 87,002 | $99.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 95,683 | $109.1K | 0.00% | +95,683 | New |
| Citadel Advisors LLC | 115,536 | $131.7K | 0.00% | +92,523+402.0% | Added |
| Woodline Partners LP | 145,971 | $166.4K | 0.00% | +145,971 | New |
| Two Sigma Investments, LP | 178,518 | $203.5K | 0.00% | −44,819−20.1% | Reduced |
| Morgan Stanley | 229,770 | $261.9K | 0.00% | +39,000+20.4% | Added |
| Geode Capital Management, LLC | 251,875 | $287.2K | 0.00% | +2,524+1.0% | Added |
| Two Sigma Advisers, LP | 264,900 | $302.0K | 0.00% | −3,000−1.1% | Reduced |
| BlackRock, Inc. | 323,335 | $368.6K | 0.00% | +2,424+0.8% | Added |
| Renaissance Technologies LLC | 338,600 | $386.0K | 0.00% | −46,997−12.2% | Reduced |
| Bank of America Corp | 385,312 | $439.3K | 0.00% | +20.0% | Added |
| Bank of Montreal | 422,077 | $481.2K | 0.00% | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 431,760 | $492.2K | 0.03% | −24,703−5.4% | Reduced |
| Bank of Nova Scotia | 459,194 | $523.5K | 0.00% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 593,396 | $676.5K | 0.58% | +4,180+0.7% | Added |
| Stonepine Capital Management, LLC | 627,668 | $715.5K | 0.57% | +63,755+11.3% | Added |
| Pfizer Inc | 715,295 | $815.4K | 0.34% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,080,070 | $1.23M | 0.00% | 00.0% | Unchanged |
| Almitas Capital LLC | 1,479,129 | $1.69M | 0.37% | +50,806+3.6% | Added |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,541−100.0% | Sold out |
| ACT Advisors, LLC. | 0 | $0 | 0.00% | −13,199−100.0% | Sold out |
| Highline Wealth Partners LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |